SecBot SecBot
SECBOTREPLAY Home › Report › KYMR

KYMR · Two institutional affiliates of Atlas Venture, Atlas Venture Fund X,…

Kymera Therapeutics, Inc. · 144 filed Apr 15, 2026 at 16:51 ET

At the news

NEUTRALIMPACT 3/10

144 filed Apr 15, 2026 at 16:51 ET

Two institutional affiliates of Atlas Venture, Atlas Venture Fund X, L.P. and Atlas Venture Opportunity Fund I, L.P., filed notices to sell a combined 3,135 shares of Kymera Therapeutics (KYMR) stock, valued at approximately $281,742. The filings were submitted on the same day, signaling coordinated intent to divest small positions.

  • Atlas Venture Fund X, L.P. intends to sell 2,750 shares, valued at $247,142.50.
  • Atlas Venture Opportunity Fund I, L.P. intends to sell 385 shares, valued at $34,599.95.
  • Total proposed sale: 3,135 shares worth $281,742.45.
  • Sales are planned through Merrill Lynch on Nasdaq, with filing dates of April 15, 2026.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access